Richa Jaiswal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Richa Jaiswal has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Nagaraj Sanchitha Honganur
Department Internal Medicine, Parkview Medical Center, Pueblo, USA
2 shared publications - Urvish K. Patel
Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2 shared publications - Aelia Akbar
Public Health, Loyola University Medical Center, Chicago, USA
1 shared publication - Aran Deol
Department of Internal Medicine, Swedish Covenant Hospital, Chicago, USA
1 shared publication - Azadeh Khayyat
Internal Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IRN
1 shared publication - Azka Zergham
Department of Internal Medicine, Larkin Community Hospital, Hialeah, USA
1 shared publication
Latest Publications
- Open Access
- 9 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24850
Cardiac Sarcoidosis Diagnostic Challenges and Management: A Case Report and Literature Review
Sarcoidosis can be presented as cardiac sarcoidosis (CS), which is challenging to diagnose due to its clinical silence. Ventricular arrhythmias and atrioventricular blocks can be fatal and cause sudden death in patients with cardiac sarcoidosis. Five percent of sarcoidosis patients have clinically evident cardiac sarcoidosis. However, autopsy reports and imaging studies have shown a higher prevalence of cardiac involvement. Early recognition is important to prevent such detrimental consequences. Cardiac sarcoidosis is increasingly being diagnosed owing to increased awareness among physicians and new diagnostic tools like MRI and positron emission tomography (PET) scan replacing traditional endomyocardial biopsy. A definitive diagnosis of CS remains challenging due to the non-specific clinical findings that can present similar symptoms of common cardiac disease; therefore, the imaging and biopsies are substantial for diagnosis confirmation. Pharmacological and Implantable devices are two main therapeutic approaches in cardiac sarcoidosis, in which steroids and pacemaker therapy have shown better outcomes. This review summarizes the available data related to the prevalence, prognosis, diagnosis, and management of cardiac sarcoidosis.
- 9 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24850
Open AccessCardiac Sarcoidosis Diagnostic Challenges and Management: A Case Report and Literature Review
Sarcoidosis can be presented as cardiac sarcoidosis (CS), which is challenging to diagnose due to its clinical silence. Ventricular arrhythmias and atrioventricular blocks can be fatal and cause sudden death in patients with cardiac sarcoidosis. Five percent of sarcoidosis patients have clinically evident cardiac sarcoidosis. However, autopsy reports and imaging studies have shown a higher prevalence of cardiac involvement. Early recognition is important to prevent such detrimental consequences. Cardiac sarcoidosis is increasingly being diagnosed owing to increased awareness among physicians and new diagnostic tools like MRI and positron emission tomography (PET) scan replacing traditional endomyocardial biopsy. A definitive diagnosis of CS remains challenging due to the non-specific clinical findings that can present similar symptoms of common cardiac disease; therefore, the imaging and biopsies are substantial for diagnosis confirmation. Pharmacological and Implantable devices are two main therapeutic approaches in cardiac sarcoidosis, in which steroids and pacemaker therapy have shown better outcomes. This review summarizes the available data related to the prevalence, prognosis, diagnosis, and management of cardiac sarcoidosis.
- 16 February 2021
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 3 (4) , 971-978
Prevalence and Outcomes of Cerebrovascular and Cardiovascular Events Among Transient Ischemic Attack Patients—a Cross-Sectional Study of National Estimate
- 16 February 2021
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 3 (4) , 971-978
Prevalence and Outcomes of Cerebrovascular and Cardiovascular Events Among Transient Ischemic Attack Patients—a Cross-Sectional Study of National Estimate